𝐀𝐥𝐜𝐨𝐧 𝐌𝐚𝐤𝐢𝐧𝐠 𝐌𝐨𝐯𝐞𝐬

Alcon has announced its agreement to acquire STAAR Surgical, a global leader in implantable lenses for refractive surgery. This strategic move will significantly strengthen Alcon’s footprint in the Implantable Collamer Lens (ICL) market — giving patients more alternatives to glasses and LASIK.
⭐ By leveraging Alcon’s worldwide reach and STAAR Surgical’s expertise in ICL technology, this acquisition could transform refractive surgery options and expand access for patients worldwide.
David Endicott, CEO of Alcon, put it perfectly:
“This transaction will allow us to provide treatment options across the full spectrum of myopia—from contact lenses to surgical interventions—reinforcing our commitment to addressing the most significant needs in eye care.”
As refractive surgery continues to evolve, partnerships like this one will drive innovation, improve patient outcomes, and shape the future of vision care.